Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
/in International Publications, Newcastle Disease Virus, Ovarian Cancer /von 2018-09-11 / Clin. Cancer Res. 2019 Mar;25(5):1624-1638The Role of Oncolytic Viruses in the Treatment of Melanoma
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2018-08-25 / Curr Oncol Rep 2018 08;20(10):80Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2018-08-01 / Am J Cancer Res 2018;8(8):1514-1527Integrating oncolytic viruses in combination cancer immunotherapy
/in International Publications, Newcastle Disease Virus /von 2018-08-01 / Nat. Rev. Immunol. 2018 Aug;18(8):498-513Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-07-31 / Sci Rep 2018 Jul;8(1):11470Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
/in International Publications, Newcastle Disease Virus, Thyroid Cancer /von 2018-07-18 / BMC Cancer 2018 Jul;18(1):746Recurrent Glioblastoma Treated with Recombinant Poliovirus
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-06-26 / N. Engl. J. Med. 2018 07;379(2):150-161Exploiting Viruses to Treat Diseases
/in International Publications, Newcastle Disease Virus /von 2018-06-26 / N. Engl. J. Med. 2018 07;379(2):194-196Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-06-19 / Oncotarget 2018 Jun;9(47):28702-28716IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de